GB0013090D0 - Intergrin-targetting vectors having enhanced transfection activity - Google Patents
Intergrin-targetting vectors having enhanced transfection activityInfo
- Publication number
- GB0013090D0 GB0013090D0 GB0013090A GB0013090A GB0013090D0 GB 0013090 D0 GB0013090 D0 GB 0013090D0 GB 0013090 A GB0013090 A GB 0013090A GB 0013090 A GB0013090 A GB 0013090A GB 0013090 D0 GB0013090 D0 GB 0013090D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- intergrin
- transfection activity
- enhanced transfection
- targetting
- vectors
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
- 238000001890 transfection Methods 0.000 title 1
- 239000013598 vector Substances 0.000 title 1
Priority Applications (9)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB0013090A GB0013090D0 (en) | 2000-05-30 | 2000-05-30 | Intergrin-targetting vectors having enhanced transfection activity |
| US10/296,879 US20040014217A1 (en) | 2000-05-30 | 2001-05-30 | Methods of transfection |
| PCT/GB2001/002394 WO2001092542A2 (en) | 2000-05-30 | 2001-05-30 | Integrin-targeting vectors having enhanced transfection activity |
| CA002410419A CA2410419A1 (en) | 2000-05-30 | 2001-05-30 | Improved methods of transfection |
| AU2001258659A AU2001258659A1 (en) | 2000-05-30 | 2001-05-30 | Improved methods of transfection |
| AU2001260467A AU2001260467A1 (en) | 2000-05-30 | 2001-05-30 | Integrin-targeting vectors having enhanced transfection activity |
| JP2002500735A JP2003534804A (en) | 2000-05-30 | 2001-05-30 | How to improve transfection |
| PCT/GB2001/002396 WO2001092543A2 (en) | 2000-05-30 | 2001-05-30 | Improved methods of transfection |
| EP01931977A EP1285081A2 (en) | 2000-05-30 | 2001-05-30 | Improved methods of transfection |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB0013090A GB0013090D0 (en) | 2000-05-30 | 2000-05-30 | Intergrin-targetting vectors having enhanced transfection activity |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GB0013090D0 true GB0013090D0 (en) | 2000-07-19 |
Family
ID=9892608
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GB0013090A Ceased GB0013090D0 (en) | 2000-05-30 | 2000-05-30 | Intergrin-targetting vectors having enhanced transfection activity |
Country Status (1)
| Country | Link |
|---|---|
| GB (1) | GB0013090D0 (en) |
-
2000
- 2000-05-30 GB GB0013090A patent/GB0013090D0/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU7025201A (en) | Expression vectors | |
| GB0012671D0 (en) | Therapeutic agents | |
| GB0003397D0 (en) | Therapeutic agents | |
| GB0004003D0 (en) | Therapeutic agents | |
| GB0017256D0 (en) | Therapeutic agents | |
| EP1154755A4 (en) | Liposome formulations | |
| GB0005789D0 (en) | Therapeutic agents | |
| GB0007907D0 (en) | Therapeutic agents | |
| GB0012214D0 (en) | Therapeutic agents | |
| GB0008696D0 (en) | Therapeutic agents | |
| GB0000564D0 (en) | Therapeutic agents | |
| IL154364A0 (en) | Arylalkane-sulfonamides having endothelin-antagonist activity | |
| GB0017518D0 (en) | Therapeutic agents | |
| GB9926529D0 (en) | Targeting agents | |
| GB0007376D0 (en) | Therapeutic agents | |
| AU2001260467A1 (en) | Integrin-targeting vectors having enhanced transfection activity | |
| GB0028849D0 (en) | Improved keysheath | |
| GB9906615D0 (en) | Vector | |
| GB0008936D0 (en) | Vectors | |
| GB0013090D0 (en) | Intergrin-targetting vectors having enhanced transfection activity | |
| GB0008966D0 (en) | Vectors for gene therapy | |
| GB2365335B (en) | Hairdryer | |
| GB0004254D0 (en) | Improved capodastro | |
| GB9909446D0 (en) | Vector | |
| GB2364426B (en) | Improved capodastro |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| AT | Applications terminated before publication under section 16(1) |